Vi Antigen from Salmonella typhosa and Immunity Against Typhoid Fever I. Isolation and Immunologic Properties in Animals
AUTOR(ES)
Wong, K. H.
RESUMO
The role of Vi antigen in human immunity against typhoid fever has been debated for decades. Circumstantial evidence indicates that Vi antigen may play a role in pathogenicity and immunity. A Vi preparation was isolated from Salmonella typhosa, the causative organism in human typhoid fever, by a mild precipitation method. It was significantly more potent in animal studies than preparations from Citrobacter used in the past for human study and less toxic than conventional typhoid vaccines. With this antigen, the role of Vi antigen in human protection is now being investigated.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=414808Documentos Relacionados
- Vi antigen from Salmonella typhosa and immunity against typhoid fever. 11. Safety and antigenicity in humans.
- Genetic Transfer of the Vi Antigen from Salmonella typhosa to Escherichia coli
- Application of optical properties of the Vi capsular polysaccharide for quantitation of the Vi antigen in vaccines for typhoid fever.
- Ineffectiveness of Vi and chemically treated endotoxins as typhoid vaccines in mice challenged with a Salmonella typhosa-Salmonella typhimurium hybrid.
- VI-NEGATIVE STRAINS OF SALMONELLA TYPHOSA: ATTEMPTS TO INDUCE W-V REVERSION AND THE USE OF NON-VI STRAINS IN EVALUATING TYPHOID VACCINES